Author:
Şandru Florica,Petca Aida,Gheorghe Ana-Maria,Petrova Eugenia,Ghemigian Adina,Petca Răzvan,Carsote Mara,Dumitraşcu Mihai-Cristian,Nistor Claudiu-Eduard
Reference35 articles.
1. Claahsen-van der Grinten HL, Speiser PW, Ahmed SF, Arlt W, Auchus RJ, Falhammar H, Flück CE, Guasti L, Huebner A, Kortmann BBM, Krone N, Merke DP, Miller WL, Nordenström A, Reisch N, Sandberg DE, Stikkelbroeck NMML, Touraine P, Utari A, Wudy SA, White PC. Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management. Endocr Rev. 2022;43(1):91-159.
2. Zhang LK, Liu ZY. Interpretation of the 5th edition WHO classification of adrenal cortical tumors. Zhonghua Bing Li Xue Za Zhi. 2024;53(1):16-21.
3. Held PK, Bird IM, Heather NL. Newborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening Accuracy. Int J Neonatal Screen. 2020;6(3):67.
4. Parsa AA, New MI. Steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia. J Steroid Biochem Mol Biol. 2017;165(Pt A):2-11.
5. Spandri A, Cogliardi A, Maggi P, De Giorgi A, Masperi R, Beccaria L. Congenital adrenal hyperplasia. Arch Ital Urol Androl. 2004;76(3):143-6.